AwardedSpainGoods€6,750,700
Suministro de medicamentos exclusivos con principio activo Nirsevimab del laboratorio farmacéutico Sanofi Aventis, S.A.
- Published
- Published 18 February 2026
Overview
Medicamentos exclusivos con principio activo Nirsevimab
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Estimated value
- €6,750,700
- Procedure
- Direct
- Published
- 18 February 2026
Immune sera and immunoglobulins
Award outcome
- Awarded value
- €5,600,000
- Award date
- 15 January 2026
- SANOFI AVENTIS, S.A.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
18 February 2026
Contracting authority
Servicio Murciano de Salud - Junta de Compras
Procuring entityEspinardo, Spain
ID_PLATAFORMA: 41261690169929
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.